학술논문
Favorable Outcomes in CLL Pts with Alternate Kinase Inhibitors Following Ibrutinib or Idelalisib Discontinuation: Results from a Large Multi-Center Study
Document Type
Abstract
Author
Mato, Anthony ; Nabhan, Chadi; Barr, Paul M.; Ujjani, Chaitra S.; Hill, Brian T.; Lamanna, Nicole; Skarbnik, Alan P; Howlett, Christina ; Pu, Jeffrey J; Sehgal, Alison R.; Strelec, Lauren E. ; Vandegrift, Alexandra ; Rago, Allison ; Zent, Clive S; Feldman, Tatyana; Goy, Andre; Claxton, David F.; Bachow, Spencer Henick ; Kaur, Gurbakhash ; Svoboda, Jakub; Dwivedy Nasta, Sunita; Porter, David; Landsburg, Daniel J.; Schuster, Stephen J.; Cheson, Bruce D.; Evens, Andrew M.
Source
In Blood 3 December 2015 126(23):719-719
Subject
Language
ISSN
0006-4971